Loading clinical trials...
Loading clinical trials...
This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receivi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT05685238 · Haemophilia A, Haemophilia A With Inhibitors
NCT04083781 · Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
NCT02137850 · Congenital Bleeding Disorder, Haemophilia A
NCT02141074 · Congenital Bleeding Disorder, Haemophilia B
NCT05053139 · Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk Investigational Site
Princeton, New Jersey
Novo Nordisk Investigational Site
Prov. de Buenos Aires
Novo Nordisk Investigational Site
Mississauga
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions